This promotional program is being provided by Genentech BioOncology and Biogen Idec.
Emerging Trends in Lymphoma Diagnosis and Staging for Advanced Practice
RSVP Now
Learning Objectives
At the end of this presentation, the participant will be able to:
- Summarize past and current trends in lymphoma diagnosis and staging.
- Identify successful strategies to making treatment decisions through a team-care approach.
- List nursing strategies for effective patient communication.
Target Audience
This program is intended for oncology nurses interested in learning about recent advances and emerging trends in the delivery of care to patients with non-Hodgkin’s lymphoma.
Program Overview
Non-Hodgkin’s lymphomas (NHLs) are a heterogeneous group of lymphoproliferative malignancies divided into two clinically relevant prognostic categories, indolent and aggressive lymphomas. As a group they are the fifth most commonly diagnosed cancer in the United States, with approximately 1.5 million new cases per year.
Join us for a case-based discussion that will provide insight into recent advances and emerging trends in the delivery of care to patients with NHL.
This program will examine issues in treating NHL, including appropriate work-up and diagnosis, accurate staging, navigation of treatment algorithms, management of patients through relapse and transformation, management of side effects, and helping patients transition to a life with lymphoma.
Faculty
Michele Walsh, RN, MS, FNP
Dana Farber Cancer Institute
Boston, MA
This promotional ancillary event is being held in conjunction with ONS 33rd Annual Congress.
RSVP Deadline May 9, 2008 at 5 pm.
Program Outline
TIME |
TOPIC |
PRESENTER |
6:00 – 6:15
6:15 – 6:45
6:45 – 7:15
7:15 – 7:45
7:45 – 8:00
8:00 |
Welcome and Program Introduction
NHL Overview
Diagnosis, Staging, and Prognosis
Treatment, Recurrence, and Remission
Questions and Answers
Program Concludes |
Stephanie Barrett, RN, BSN, ONSEdge
Michele Walsh, RN, MS, FNP
Michele Walsh, RN, MS, FNP
Michele Walsh, RN, MS, FNP
Michele Walsh, RN, MS, FNP
Michele Walsh, RN, MS, FNP |
NOTE: NO continuing nursing education (CNE) contact hours will be awarded. In order to register for this event you must acknowledge that this program does NOT offer continuing nursing education.
ONSEdge, Inc., has been assigned meeting space to provide a promotional ancillary event
funded by Genentech and Biogen Idec during the during the Oncology Nursing Society’s (ONS)
33rd Annual Congress, May 15-18, 2008 in Philadelphia, Pennsylvania. The Oncology Nursing
Society’s assignment of meeting space does not imply product endorsement nor does the
Oncology Nursing Society assume any responsibility for the content.
RSVP Now
|
